Drug Trial Radar · NCT06867107
An Open-label Long-term Follow-up Study of SAT-3247 for Participants With Duchenne Muscular Dystrophy Including Those Who Participated in SAT-3247-CL-101
Last checked: Nov 19, 2026Latest source record: Nov 19, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
30
Planned (sponsor's estimate)
Start
Sep 25, 2025
Primary completion
Sep 30, 2027
Study completion Sep 30, 2027
Sponsor
- Lead sponsor
- Satellos Bioscience, Inc.Industry
- Sponsor type
- Industry
- First posted
- Mar 10, 2025
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- Male only, from 16 years, up to 40 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is an open-label long-term safety and efficacy study of orally administered SAT-3247 in patients with DMD including those who previously participated in SAT-3247-CL-101. The study will assess the long-term safety, tolerability and potential efficacy of long-term dosing of orally administered SAT-3247 60 mg in a 5-days on/2-days off (i.e. weekday dosing) regimen in an open-label design through 11 months (Group A) or 12 months (Group B), respectively. The study will enroll up to 30 participants, including up to 5 who previously participated in the SAT-3247-CL-101 study.
Conditions
- Duchenne Muscular Dystrophy (DMD)
Interventions
SAT-3247Drug
AAK1 inhibitor
Primary outcomes
What the sponsor says the trial is designed to measure.
- Treatment emergent adverse eventsTime frame: 12 months
- SAT-3247 effect on fat fraction in biceps brachiiTime frame: 12 months
Locations
6 sites in 2 countries. Site status is shown where the registry gives one.
University of California, Los Angeles
Los Angeles, California · Recruiting
Washington University School of Medicine
St Louis, Missouri · Not yet recruiting
Nationwide Children's Hospital
Columbus, Ohio · Recruiting
St. Jude Children's Research Hospital
Memphis, Tennessee · Not yet recruiting
The Royal Children's Hospital
Melbourne, Victoria, Australia · Not yet recruiting
St. Vincent Hospital
Melbourne, Victoria, Australia · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.